Mom did receive betamethasone x1 prior to delivery.
The abdomen exam is consistent with a nondistended, nontender abdomen with no masses palpable.
The patient does have a small, approximately 0.5 cm scar in the right upper quadrant of the abdomen which is the location of a chest tube placed for pneumothorax.
These scars are covered with Steri-Strips and appear pink and well perfused with no significant erythema or pus.
SUMMARY OF HOSPITAL COURSE BY SYSTEMS:  Respiratory: This patient was initially placed on high frequency ventilation until day of life 7.
This patient was transferred from high frequency to conventional ventilation on day of life 7 and remained on conventional ventilation until day of life 11.
This patient was then weaned to nasal cannula until day of life 69.
This patient also had a presumed pulmonary hemorrhage due to bloody secretions that were obtained from the endotracheal tube on day of life [**6-9**].
This patient did have a right-sided pneumothorax that was noted in the 1st week of life and a chest tube was placed.
The patient's caffeine was discontinued on day of life 64 which was equal to 36 and 1/7 weeks post menstrual age.
Cardiovascular: This patient did have a patent ductus arteriosus and was treated with indomethacin for 2 courses.
Fluids, electrolytes and nutrition: This patient was placed on total parenteral nutrition for the first 2 weeks of life.
Feedings were not started until day of life 13 because the patient was receiving indomethacin for the patent ductus arteriosus as previously mentioned.
The NICU team started this patient on a 7-day course of ranitidine for possible esophagitis.
It is recommended that this patient complete a 7-day course at this dose and then the pediatrician consider a maintenance dose of ranitidine for reflux.
This patient will be discharged home with Enfamil AR with a few feedings with breast milk when available.
This patient had a bilateral hernia repair performed by Dr. [**First Name4 (NamePattern1) **] [**Last Name (NamePattern1) **] of [**Hospital3 18242**] [**Location (un) 86**] on [**2182-4-17**].
A circumcision was performed after the surgery.
Infectious disease: This patient was initially treated with ampicillin and gentamicin for 14 days at birth.
Ampicillin and gentamicin were started due to concerns for sepsis related to mom's premature rupture of membranes and delivery.
The patient was initially started on vancomycin and gentamicin and when sensitivities returned the patient was transitioned to penicillin to treat the group B Strep bacteremia.
The patient completed a 14-day course of antibiotics for the group B Strep bacteremia.
One of the blood transfusions was received after the blood-tinged secretions from the endotracheal tube were found as previously mentioned.
This patient had anemia of prematurity and was treated during the hospitalization with iron and vitamin E. The most recent hematocrit performed prior to discharge on [**4-4**] was 30.4 with a reticulocyte count of 2.2%.
This patient will be discharged home with supplemental iron sulfate of 2 mg of elemental sulfate per kg per day.
This patient was followed several times during the hospitalization and the most recent exam was performed on [**2182-4-25**].
Medications at discharge:    1.
Ferrous sulfate (concentration 25 mg/mL) 0.4 mL PO         daily (=2 mg of elemental iron/kg/day)    2.
Ranitidine 10 mg p.o.
Ranitidine: We recommended this patient complete a          7-day course of ranitidine at a dose of 10 mg p.o.
After this          is completed, we recommend starting ranitidine at a          dose for treatment of gastroesophageal reflux          (recommended 2 mg/k/dose PO q8 hours).
Immunizations received during this hospitalization include hepatitis B vaccine on [**2182-2-17**] and Pediarix, Hib, pneumococcal 7-valent conjugate vaccine on [**2182-3-24**].
This patient also had Synagis vaccine performed on [**2182-4-15**].
Immunizations recommended: Synagis RSV prophylaxis should be considered from [**Month (only) **]-[**Month (only) 958**] for infants who meet any of the following 4 criteria: 1.
Influenza immunization is recommended annually in the fall for all infants once they reach 6 months of age.
Before this age, and for the first 24 months of a child's life immunization against influenza is recommended for household contacts and out of home caregivers.
Patent ductus arteriosus, status post indomethacin      treatment, resolved 11.
Bilateral inguinal hernias status post repair 12.
